Drug Type ASO |
Synonyms- |
Target |
Action inhibitors |
Mechanism Nav1.7 inhibitors(Sodium channel protein type IX alpha subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cancer Pain | Preclinical | United States | 19 Apr 2024 | |
| Lumbosacral Radiculopathy | Discovery | United States | 19 Apr 2024 | |
| Small Fiber Neuropathy | Discovery | United States | 19 Apr 2024 |





